William Blair & Company’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

William Blair & Company’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35	Closed	-$1.1K	–	1843
2023 Q2	$1.1K	Buy	+35	New	+$1.09K	﹤0.01%	1790
2023 Q1	–	Sell	-3,344	Closed	-$102K	–	1847
2022 Q4	$102K	Hold	3,344	–	–	﹤0.01%	1487
2022 Q3	$101K	Sell	3,344 -480	-13%	-$15.2K	﹤0.01%	1509
2022 Q2	$106K	Hold	3,824	–	–	﹤0.01%	1533
2022 Q1	$129K	Hold	3,824	–	–	﹤0.01%	1604
2021 Q4	$162K	Hold	3,824	–	–	﹤0.01%	1622
2021 Q3	$174K	Buy	+3,824	New	+$176K	﹤0.01%	1530
2021 Q2	–	Sell	-300	Closed	-$15K	–	1921
2021 Q1	$15K	Buy	+300	New	+$16.6K	﹤0.01%	1768
2019 Q1	–	Sell	-335	Closed	-$9K	–	1735
2018 Q4	$9K	Buy	335 +10	+3%	+$332	﹤0.01%	1571
2018 Q3	$13K	Hold	325	–	–	﹤0.01%	1557
2018 Q2	$12K	Buy	+325	New	+$11.8K	﹤0.01%	1524

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

William Blair & Company's SBIO Position: Q3 2023 in Review

William Blair & Company sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2023, closing a stake of 35 shares — an estimated $1.1K sold.

William Blair & Company first reported a position in SBIO in Q2 2018 and held it in 11 quarters. The position peaked at $174K in Q3 2021. 36 funds tracked by Wall St. Rank hold SBIO as of Q3 2023.

William Blair & Company reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2023 after selling out during the quarter.
William Blair & Company sold 35 ALPS Medical Breakthroughs ETF shares in Q3 2023, an estimated $1.1K.
William Blair & Company first reported a position in ALPS Medical Breakthroughs ETF in Q2 2018 and held it in 11 quarters.
William Blair & Company's ALPS Medical Breakthroughs ETF position peaked at $174K in Q3 2021.
36 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2023.

Based on William Blair & Company's 13F filing for Q3 2023, filed 9 Nov 2023.